Companies

Chai Discovery

chaidiscovery.com

AI-driven molecular design platform enabling rapid drug discovery and antibody design

HQSan Francisco
Employees11-50
Funding$230M
Valuation$1.3B
Revenue$1M ARR
14 active roles
Healthcare AIFoundation Model ProviderB2B SaaSSeries B$200M-$1B

About

Chai Discovery develops AI-based platforms for molecular design and drug discovery, including foundation models for molecular structure prediction and antibody design, enabling researchers to generate and evaluate novel molecules. The company targets pharma and biotech researchers and partners with scientific teams to accelerate discovery workflows.

Active Roles

14
San Francisco office/Engineering/19d ago
San Francisco office/HR & Recruiting/117d ago
San Francisco office/Data & Analytics/147d ago
San Francisco office/Other/151d ago
San Francisco office/Sales/151d ago
San Francisco office/Engineering/151d ago
San Francisco office/Forward-Deployed Engineer/151d ago
San Francisco office/Data & Analytics/151d ago
San Francisco office/Engineering/151d ago
San Francisco office/Engineering/151d ago
San Francisco office/Sales/151d ago
San Francisco office/Other/151d ago
San Francisco office/Other/151d ago
San Francisco office/Engineering/151d ago

Key Investors

Emerson Collective, General Catalyst, Glade Brook Capital Partners, Oak HC/FT, Thrive Capital